Mindset Pharma 将来の成長
Future 基準チェック /26
Mindset Pharma's earnings are forecast to decline at 22% per annum while its annual revenue is expected to grow at 43.8% per year. EPS is expected to decline by 3.3% per annum.
主要情報
-22.0%
収益成長率
-3.3%
EPS成長率
| Pharmaceuticals 収益成長 | 54.4% |
| 収益成長率 | 43.8% |
| 将来の株主資本利益率 | n/a |
| アナリストカバレッジ | Low |
| 最終更新日 | 30 Jun 2023 |
業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 6/30/2026 | 3 | -51 | -74 | N/A | 2 |
| 6/30/2025 | 8 | -34 | -35 | N/A | 2 |
| 6/30/2024 | 11 | -21 | -20 | N/A | 2 |
| 6/30/2023 | 9 | -9 | -5 | N/A | 2 |
| 3/31/2023 | 8 | -6 | -5 | -5 | N/A |
| 12/31/2022 | 8 | -5 | 6 | 6 | N/A |
| 9/30/2022 | 6 | -9 | 4 | 4 | N/A |
| 6/30/2022 | 4 | -17 | 0 | 0 | N/A |
| 3/31/2022 | 2 | -21 | -1 | -1 | N/A |
| 12/31/2021 | N/A | -21 | -12 | -12 | N/A |
| 9/30/2021 | N/A | -16 | -10 | -10 | N/A |
| 6/30/2021 | N/A | -12 | -8 | -8 | N/A |
| 3/31/2021 | N/A | -7 | -5 | -5 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: MSET is forecast to remain unprofitable over the next 3 years.
収益対市場: MSET is forecast to remain unprofitable over the next 3 years.
高成長収益: MSET is forecast to remain unprofitable over the next 3 years.
収益対市場: MSET's revenue (43.8% per year) is forecast to grow faster than the Canadian market (6.8% per year).
高い収益成長: MSET's revenue (43.8% per year) is forecast to grow faster than 20% per year.
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: Insufficient data to determine if MSET's Return on Equity is forecast to be high in 3 years time